MDxHealth (MDXH) Return on Equity (2022 - 2026)

MDxHealth has disclosed Return on Equity across 5 years of filings, most recently posting 0.02% for Q1 2026.

• Return on Equity for Q1 2026 came in at 0.02%, up 5.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.02% (up 5.0% YoY), and the FY2025 annual result was 0.0%, up 3.0% from the prior year.
• Return on Equity came in at 0.02% for Q1 2026 at MDxHealth, down from 0.03% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.08% in Q2 2024 to a low of 11.77% in Q4 2022.
• The 5-year median for Return on Equity is 0.02% (2024), against an average of 1.46%.
• Across the five-year window, Return on Equity jumped 1174 bps in 2023 and slipped 8 bps in 2024, its largest moves.
• MDxHealth's Return on Equity stood at 11.77% in 2022, then surged by 100 bps to 0.03% in 2023, then jumped by 31 bps to 0.02% in 2024, then soared by 219 bps to 0.03% in 2025, then plunged by 38 bps to 0.02% in 2026.
• The last three Return on Equity figures came in at 0.02% (Q1 2026), 0.03% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.